Rankings
▼
Calendar
RCUS FY 2025 Earnings — Arcus Biosciences, Inc. Revenue & Financial Results | Market Cap Arena
RCUS
Arcus Biosciences, Inc.
$2B
FY 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$247M
-4.3% YoY
Gross Profit
$237M
96.0% margin
Operating Income
-$386M
-156.3% margin
Net Income
-$353M
-142.9% margin
EPS (Diluted)
$-3.29
Cash Flow
Operating Cash Flow
-$482M
Free Cash Flow
-$484M
Stock-Based Comp.
$60M
Balance Sheet
Total Assets
$1.1B
Total Liabilities
$508M
Stockholders' Equity
$631M
Cash & Equivalents
$222M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$247M
$258M
-4.3%
Gross Profit
$237M
$258M
-8.1%
Operating Income
-$386M
-$330M
-17.0%
Net Income
-$353M
-$283M
-24.7%
← Q4 2024
All Quarters
Q1 2025 →